Connect with us

Entertainments

Jadrolita Reveals Battle with Jawline Tumor Amidst Fan Speculations

Published

on

By Iyojo Ameh

Amadou Elizabeth, popularly known as Jadrolita, a well-known content creator famed for her unique robotic-themed performances, has revealed she is currently battling a tumor in her jawline.

This revelation comes on the heels of rising speculation from fans regarding her abrupt absence from social media. Some followers had previously criticized her silence, attributing it to an alleged relationship with fellow TikTok influencer, Peller.

She revealed in a recent video that she has been battling with a tumor in her jawline, which she initially thought was a dental issue.

The content creator said she will soon undergo surgery, adding that the tumour is spoiling her face.

“The tumor is spoiling my face

“Let me tell you people what happened. I was told that I have a tumour here. I thought it was a teeth problem, but it’s not teeth. The doctor said it was a tumour in my jawline,” she said.

Speaking further in the video, Jadrolita shared details about her medical journey.

“So the last time I went, they removed something from inside, like they opened it and took from it to go and test what kind of tumor it is before I go for the main surgery.

“I haven’t gone for the main surgery, but I heard that the result is out, so let’s see. I just pray it is not bad because it is spoiling my face. And those people that were saying I should go back to AI, did they not see that the face of the previous AI was fresh, there wasn’t whatever on her face.

See also  Winners Announced at the 10th Africa Magic Viewers’ Choice Awards (AMVCA) 2024

“This new AI has ‘puff puff,’ so I don’t know how they want me to do it. I don’t know, but anyway, for all of you that are shouting, why are you shouting? Calm down”, she added.

She however, reassured her followers that her break was entirely related to her health and not due to personal relationships, urging fans to remain patient as she focuses on recovery.

0Shares
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *